Yi DD, Li GM, Li G, Liang W. Interaction of arginine oligomer with model membrane.
BIOCHEM BIOPHYS RES COMMUN, 2007; 359(4): 1024-1029
Tang N, Du GJ, Wang N, Liu CC, Hang HY, Liang W Improving penetration in tumors
with nanoassemblies of phospholipids and doxorubicin. J NATI CANCER INST. 2007;
99 (13): 1004-1015
Lin HY, Lu XY, Tang N, Liang W. VCR encapsulated in phospholipid micelles to improve
effect of growth inhibition on MCF-7 cells. PROG BIOCHEM BIOPHY, 2006; 33(8): 769-774
Zhang CL, Tang N, Liu XJ, Liang W, Xu W, Torchilin VP siRNA-containing liposomes
modified with polyarginine effectively silence the targeted gene. J CONTROL RELEASE,
2006; 112(2): 229-239
Liu XJ, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M. Smad3 specific inhibitor,
naringenin, decreases the expression of extracellular matrix induced by TGF-beta
1 in cultured rat hepatic stellate cells. PHARM RES 23(1 ): 82-89 (缺年代）
Wiedmann T.S., Liang w., and Herrington
H. Excluded volume effect of rat intestinal mucin on taurocholate/phosphatidylcholine
mixed micelles. J COLLOID INTERF SCI
270 (2), 321-328 (2004).
Wiedmann T.S., Liang w., and Herrington
H. Interaction of bile salts with gastrointestinal mucins. Lipids,
39 (1), 51-58 (2004).
Liang w., Levchenko T.S., Khaw B. A.,
Torchilin V.P. ATP-contaning immunoliposomes specific toward cardiac
myosin. Curr Drug DeliV 1 (1), 1-7 (2004).
Liao X., Liang W., Wattenverg A. D.
and Wiedmann T.S.,., et al. The Lung distribution of the chemopreventive
agent, DFMO, following oral and inhalation delivery. CARCINOGENESIS,
(2004).
Wiedmann T.S., Liang w., and Kamel L.
Solubilization of drug by physiological mixtures of bile salts. PHARM RES 19 (8), 1203-1208 (2002).
发明专利：
发明人：梁伟，王亚芹，任福正，景秋芳
发明名称： 用于改善姜黄素溶出度和生物利用度的药物组合及其制备方法
中国发明专利号：ZL 2003 10118422.0。
发明人：梁伟，付颉，王亚芹，刘建蓉，侯全民
发明名称：一种新型的聚乙二醇衍生化磷脂包载前列腺素E1的纳米微粒给药系统
中国发明专利号： ZL 2004 10057147.0。
发明人：梁伟，唐宁，张春玲，饶子和
发明名称：聚乙二醇衍生化磷脂包载的蒽环类抗肿瘤抗生素纳米胶束制剂
国际发明专利号：WO2006/102800。
梁伟研究员